From WSJopinion: Social-media companies are censoring information about the Covid-19 treatment my company is developing after Trump mentioned it, writes josh_disbrow
I ran an obscure pharmaceutical company until a few days ago. Then we got famous. Early in the Covid-19 pandemic, Aytu BioScience made a commitment to find ways to help. One of those ways came through our newly formed relationship with a prominent Los Angeles hospital.
On April 20 we put out a press release titled “Aytu BioScience Signs Exclusive Global License with Cedars-Sinai for Potential Coronavirus Treatment.” The treatment is called Healight, and it was developed by research physicians at the hospital’s Medically Associated...
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Popular heartburn medicine being studied as treatment for coronavirusOver the past few weeks researchers have been discreetly studying a new potential treatment for COVID-19 – and it might not be what you expect.
Lire la suite »
The Cast Of 'Friends' Joins The 'All In Challenge': Everything To Know About The TrendJustin Bieber, Ciara, and Drake have also taken part in the COVID-19 relief effort.
Lire la suite »
The Cast Of 'Friends' Joins The 'All In Challenge': Everything To Know About The TrendJustin Bieber, Ciara, and Drake have also taken part in the COVID-19 relief effort.
Lire la suite »
The Cast Of 'Friends' Joins The 'All In Challenge': Everything To Know About The TrendJustin Bieber, Ciara, and Drake have also taken part in the COVID-19 relief effort.
Lire la suite »
The Cast Of 'Friends' Joins The 'All In Challenge': Everything To Know About The TrendJustin Bieber, Ciara, and Drake have also taken part in the COVID-19 relief effort.
Lire la suite »
The Cast Of 'Friends' Joins The 'All In Challenge': Everything To Know About The TrendJustin Bieber, Ciara, and Drake have also taken part in the COVID-19 relief effort.
Lire la suite »